Live event: Wednesday, June 7, 2017 | 07:00 [PDT] 10:00 [EDT] 15:00 [BST].
In this hour-long event, held in collaboration between Neuro Central and The Drake Foundation, our expert panel will discuss various aspects of brain banking and its current challenges.
Live event: Wednesday 14th June 2017 07:00 [PDT] 10:00 [EDT] 15:00 [GMT]
Assessing how drugs affect the CNS is becoming an increasing concern, particularly for road safety. In January 2015, the FDA issued the Draft Guidance – Evaluating Drug Effects on the Ability to Operate a Motor Vehicle. 2 years later, where are we now?
James Coffman responds to questions from our recent webinar, ‘How chronic stress experienced during early development epigenetically programs adult disease risk’.
Available to view on demand
Epidemiological studies have shown that chronic stress experienced very early in life—even prenatally—increases the risk of developing inflammatory disease in adulthood, including mental health disorders such as anxiety and depression.
Read the Q&A transcript and responses to the unanswered questions from our webinar on ‘Manipulation of Abuse Deterrent Formulations at the Clinical Pharmacology Unit’.
To explore the intricacies of the manipulation of abuse deterrent formulations (ADFs) in the clinical pharmacology unit (CPU) and its relationship to in vitro studies.
Available to view on demand: the UC Davis research team present an update on preclinical development of their cell-gene therapy…
In this exclusive webinar, Oncology Central Ambassador Arjun Sahgal from Sunnybrook Health Sciences Centre (ON, Canada) discusses future directions of…